BNET Industries

Santarus Inc.

(SNTS) is in the Pharma Industry

Market Cap:$289.2M
Last Fiscal Year Sales:$130.2M
  • Public
  • US
Dow Jones Description

To become a leading specialty pharmaceutical company that acquires, develops and commercializes proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.

Number of Employees 345
Contact Information

3721 Valley Centre Dr

San Diego, California 92130

santarus.com

(858) 314-5700

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Stock Picks: SNTS Up; WAG Down Market Movers

    12/02/09 - Lawsuit Filed - View Story

  • Stock Picks: SNTS Up; WAG Down

    12/02/09 - Lawsuit Filed - View Story

  • Wednesday's biggest gaining and declining stocks

    12/02/09 - Bond / Stock Rating - View Story

  • A Soothing Outcome For Santarus

    12/02/09 - Joint Venture / Alliance - View Story

  • Santarus Receives FDA Approval For Immediate-Release Omeprazole Tablet With Dual Buffers - Update

    12/04/09 - Financial Announcement - View Story

  • HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5

    11/05/09 - Financial Announcement - View Story

  • Santarus Inc executes licence agreement for ZEGERID products in Europe

    10/12/09 - Joint Venture / Alliance - View Story

  • Santarus Reports Second Quarter 2009 Financial Results

    8/03/09 - Financial Announcement - View Story

News & Analysis

nyse euronext and santarus inc. - All News and Analysis

advertisement
     SNTS $4.98 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 459,603
Shares Outstanding 58.08M
Market Cap 289.2M
Year High 5.82
Year Low 1.05
Earnings Per Share -0.07
P/E Ratio -71.14
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Click Here